Associations of miR-499 and miR-34b/c polymorphisms with susceptibility to hepatocellular carcinoma: An evidence-based evaluation

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Wang, Zhongxia ^a,b   Wu, Junhua ^c   Zhang, Guang ^a,b   Cao, Yin ^a,b   Jiang, Chunping ^a,b   Ding, Yitao ^a,b  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b Jiangsu Province's Key Medical Centre for Liver Surgery   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 34B; MICRORNA 34C; MICRORNA 499; UNCLASSIFIED DRUG;

CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HETEROZYGOSITY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84885467927     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/719202     Document Type: Review

References (51)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
2. El-Serag H. B., Hepatocellular carcinoma. The New England Journal of Medicine 2011 365 12 1118 1127 2-s2.0-80053088189 10.1056/NEJMra1001683
3. Arzumanyan A., Reis H. M. G. P. V., Feitelson M. A., Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nature Reviews Cancer 2013 13 123 135
4. El-Serag H. B., Rudolph K. L., Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007 132 7 2557 2576 2-s2.0-34250020201 10.1053/j.gastro.2007.04.061 (Pubitemid 46890874)
5. Bartel D. P., microRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5 (Pubitemid 38167318)
6. Farazi T. A., Hoell J. I., Morozov P., MicroRNAs in human cancer. Advances in Experimental Medicine and Biology 2013 774 1 20
7. Iorio M. V., Croce C. M., microRNA involvement in human cancer. Carcinogenesis 2012 33 1126 1133 10.1093/carcin/bgs140
8. Wang X. W., Heegaard N. H. H., Orum H., microRNAs in liver disease. Gastroenterology 2012 142 1431 1443 10.1053/j.gastro.2012.04.007
9. Wong C. M., Kai A. K. L., Tsang F. H. C., Ng I. O., Regulation of hepatocarcinogenesis by microRNAs. Frontiers in Bioscience (Elite Edition) 2013 5 49 60
10. Giordano S., Columbano A., microRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 2013 57 840 847 10.1002/hep.26095
11. Lovat F., Valeri N., Croce C. M., MicroRNAs in the pathogenesis of cancer. Seminars in Oncology 2011 38 6 724 733 2-s2.0-81155124251 10.1053/j.seminoncol.2011.08.006
12. Gong J., Tong Y., Zhang H.-M., Wang K., Hu T., Shan G., Sun J., Guo A.-Y., Genome-wide identification of SNPs in MicroRNA genes and the SNP effects on MicroRNA target binding and biogenesis. Human Mutation 2012 33 1 254 263 2-s2.0-84857691987 10.1002/humu.21641
13. Bandiera S., Hatem E., Lyonnet S., Henrion-Caude A., microRNAs in diseases: from candidate to modifier genes. Clinical Genetics 2010 77 4 306 313 2-s2.0-77951701375 10.1111/j.1399-0004.2010.01370.x
14. Bender M. H., Koenig L. C., Joschko N., P53 is an important regulator of micrornas in hepatocellular carcinoma. Hepatology 2010 52 951A
15. He L., He X., Lim L. P., De Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A. L., Linsley P. S., Chen C., Lowe S. W., Cleary M. A., Hannon G. J., A microRNA component of the p53 tumour suppressor network. Nature 2007 447 7148 1130 1134 2-s2.0-34250851115 10.1038/nature05939 (Pubitemid 47014436)
16. Wang J.-X., Jiao J.-Q., Li Q., Long B., Wang K., Liu J.-P., Li Y.-R., Li P.-F., MiR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nature Medicine 2011 17 1 71 78 2-s2.0-78651232227 10.1038/nm.2282
17. Akkiz H., Bayram S., Bekar A., Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pacific Journal of Cancer Prevention 2011 12 3107 3112
18. Kim W. H., Min K. T., Jeon Y. J., Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 2012 504 92 97
19. Xiang Y., Fan S., Cao J., Huang S., Zhang L.-P., Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Molecular Biology Reports 2012 39 7019 7023 2-s2.0-84856463223 10.1007/s11033-012-1532-0
20. Zhou J., Lv R., Song X., Li D., Hu X., Ying B., Wei Y., Wang L., Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA and Cell Biology 2012 31 4 524 530 2-s2.0-84859741447 10.1089/dna.2011.1340
21. Zou H.-Z., Zhao Y.-Q., Positive association between miR-499A>G and hepatocellular carcinoma risk in a Chinese population. Asian Pacific Journal of Cancer Prevention 2013 14 1769 1772
22. Xu Y., Liu L., Liu J., Zhang Y., Zhu J., Chen J., Liu S., Liu Z., Shi H., Shen H., Hu Z., A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. International Journal of Cancer 2011 128 2 412 417 2-s2.0-78649593548 10.1002/ijc.25342
23. Son M. S., Jang M. J., Jeon Y. J., Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma. Gene 2013 524 156 160 10.1016/j.gene.2013.04.042
24. Han Y. F., Pu R., Han X., Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS One 2013 8 3 e58564
25. Lau J., Ioannidis J. P. A., Schmid C. H., Quantitative synthesis in systematic reviews. Annals of Internal Medicine 1997 127 9 820 826 2-s2.0-0030693603 (Pubitemid 27465551)
26. Mantel N., Haenszel W., Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959 22 719 748
27. DerSimonian R., Laird N., Meta-analysis in clinical trials. Controlled Clinical Trials 1986 7 3 177 188 2-s2.0-0022992740 (Pubitemid 17189972)
28. White D. L., Kanwal F., El-Serag H. B., Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clinical Gastroenterology and Hepatology 2012 10 1342.e2 1359.e2
29. Huang S., He X., The role of microRNAs in liver cancer progression. British Journal of Cancer 2011 104 2 235 240 2-s2.0-78751575782 10.1038/sj.bjc.6606010
30. Salzman D. W., Weidhaas J. B., SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacology & Therapeutics 2013 137 55 63
31. Wang Z., Cao Y., Jiang C., Yang G., Wu J., Ding Y., Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. PLoS One 2012 7 e40039
32. Lafferty-Whyte K., Cairney C. J., Jamieson N. B., Oien K. A., Keith W. N., Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochimica et Biophysica Acta 2009 1792 4 341 352 2-s2.0-64549137199 10.1016/j.bbadis.2009.02.003
33. Yang B., Chen J., Li Y., Zhang J., Li D., Huang Z., Cai B., Li L., Shi Y., Ying B., Wang L., Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population. Human Immunology 2012 73 1 101 106 2-s2.0-84355161620 10.1016/j.humimm.2011.10. 005
34. Liu X. Q., Zhang Z., Sun L., Chai N., Tang S., Jin J., Hu H., Nie Y., Wang X., Wu K., Jin H., Fan D., microRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis 2011 32 12 1798 1805 2-s2.0-81855217383 10.1093/carcin/bgr213
35. Hu Z., Liang J., Wang Z., Tian T., Zhou X., Chen J., Miao R., Wang Y., Wang X., Shen H., Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Human Mutation 2009 30 1 79 84 2-s2.0-58349104128 10.1002/humu.20837
36. Zhou B., Wang K., Wang Y., Xi M., Zhang Z., Song Y., Zhang L., Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Molecular Carcinogenesis 2011 50 7 499 505 2-s2.0-79958199899 10.1002/mc.20740
37. Liu Z., Li G., Wei S., Niu J., El-Naggar A. K., Sturgis E. M., Wei Q., Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 2010 116 20 4753 4760 2-s2.0-78349281879 10.1002/cncr.25323
38. Daige C., Priddy L., Kelnar K., The development of a miRNA-based therapeutic candidate for hepatocellular carcinoma. Molecular Cancer Therapeutics 2011 10 11
39. Bommer G. T., Gerin I., Feng Y., Kaczorowski A. J., Kuick R., Love R. E., Zhai Y., Giordano T. J., Qin Z. S., Moore B. B., MacDougald O. A., Cho K. R., Fearon E. R., p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Current Biology 2007 17 15 1298 1307 2-s2.0-34547458550 10.1016/j.cub.2007.06.068 (Pubitemid 47176893)
40. Toyota M., Suzuki H., Sasaki Y., Maruyama R., Imai K., Shinomura Y., Tokino T., Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Research 2008 68 11 4123 4132 2-s2.0-49249121155 10.1158/0008-5472.CAN-08-0325
41. Kozaki K.-I., Imoto I., Mogi S., Omura K., Inazawa J., Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Research 2008 68 7 2094 2105 2-s2.0-42049104107 10.1158/0008-5472.CAN-07- 5194 (Pubitemid 351521781)
42. Lujambio A., Calin G. A., Villanueva A., Ropero S., Sánchez- Céspedes M., Blanco D., Montuenga L. M., Rossi S., Nicoloso M. S., Faller W. J., Gallagher W. M., Eccles S. A., Croce C. M., Esteller M., A microRNA DNA methylation signature for human cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 36 13556 13561 2-s2.0-51649083501 10.1073/pnas.0803055105
43. Tanaka N., Toyooka S., Soh J., Kubo T., Yamamoto H., Maki Y., Muraoka T., Shien K., Furukawa M., Ueno T., Asano H., Tsukuda K., Aoe K., Miyoshi S., Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer 2012 76 1 32 38 2-s2.0-84858006067 10.1016/j.lungcan.2011. 10.002
44. Wang Z., Chen Z., Gao Y., Li N., Li B., Tan F., Tan X., Lu N., Sun Y., Sun J., Sun N., He J., DNA hypermethylation of microRNA-34b/c has prognostic value for stage I non-small cell lung cancer. Cancer Biology and Therapy 2011 11 5 490 496 2-s2.0-79952331586 10.4161/cbt.11.5.14550
45. Vogt M., Munding J., Grüner M., Liffers S.-T., Verdoodt B., Hauk J., Steinstraesser L., Tannapfel A., Hermeking H., Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Archiv 2011 458 3 313 322 2-s2.0-79954455860 10.1007/s00428-010-1030-5
46. Gao L.-B., Li L.-J., Pan X. M., A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer. Biological Chemistry 2013 394 415 420
47. Li L., Wu J., Sima X., Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumor Biology 2013 34 1919 1923 10.1007/s13277-013-0736-9
48. Bensen J. T., Tse C. K., Nyante S. J., Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control 2013 24 1099 1109 10.1007/s10552-013-0187-z
49. Zou P., Zhao L., Xu H., Hsa-mir-499 rs3746444 polymorphism and cancer risk: a meta-analysis. Journal of Biomedical Research 2012 26 253 259 10.7555/JBR.26.20110122
50. Zhang Y. G., Shi J. X., Song C. H., Association of mir-499 and mir-149 polymorphisms with cancer risk in the Chinese population: evidence from published studies. Asian Pacific Journal of Cancer Prevention 2013 14 2337 2342 10.7314/APJCP.2013.14.4.2337
51. Xu Y., Li L., Xiang X., Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. 2013 527 2 584 593